Company Announcement Avecho reaches two-year stability milestone for its CBD softgel capsule June 22, 2023June 22, 2023
Company Announcement Avecho licenses TPM® for development of enhanced cancer drugs May 22, 2023May 22, 2023
Company Announcement Avecho commences CBD softgel manufacturing for pivotal Phase III insomnia study May 17, 2023May 17, 2023
Company Announcement Company Report Quarterly Activities Report and 4C – to 31 March 2023 April 28, 2023May 20, 2023
Company Announcement Expansion of clinical program with the Lambert Initiative February 22, 2023February 22, 2023
Company Announcement Athenex takes Avecho’s Vitamin K injection to FDA pre-IND meeting January 12, 2023January 12, 2023
Company Announcement Ethics Approval received for Phase III Clinical Trial December 22, 2022December 22, 2022
